List of works - Bruno M. Costa

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.

scientific article published on 27 March 2018

A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis

scientific article published on 10 January 2020

A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.

scientific article

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.

scientific article

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

scientific article published on 01 September 2018

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting

scientific article published on 25 July 2020

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

scientific article published on 21 October 2015

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

scientific article published on 13 August 2020

HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours

scientific article published on 01 April 2020

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer

scientific article published on 15 June 2016

Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology

scientific article published on 2 October 2017

Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.

scientific article published on 13 February 2018

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis

scientific article published in December 2017

Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.

scientific article

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

scientific article

Molecular prognostic factors in glioblastoma: state of the art and future challenges

scientific article

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer

scientific article published on 30 December 2019

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

scientific article published on 6 September 2011

Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer

scientific article published on 23 November 2021

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.

scientific article published on 3 November 2017

Serum lactate levels are associated with glioma malignancy grade

scientific article published on 01 October 2019

Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

scientific article published on 25 April 2020

The cell secretome in personalized and regenerative medicine

scientific article published on 09 November 2018

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas

scientific article published on 19 July 2018

The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.

scientific article published on 28 February 2018

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival

scientific article published on 30 December 2015

Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models

scientific article published on 19 May 2015

Understanding TERT Promoter Mutations: A Common Path to Immortality.

scientific article published on 3 March 2016

Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene

scientific article published on 10 August 2015

List of works by Bruno M. Costa

A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting TMEM97.

A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis

A semiautomated microfluidic platform for real-time investigation of nanoparticles' cellular uptake and cancer cells' tracking.

Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting

Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication

Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours

Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer

Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology

Influence of HOTAIR rs920778 and rs12826786 genetic variants on prostate cancer risk and progression-free survival.

Loss of Caveolin-1 in Metastasis-Associated Macrophages Drives Lung Metastatic Growth through Increased Angiogenesis

Mechanisms of initiation and reversal of drug-seeking behavior induced by prenatal exposure to glucocorticoids.

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities

Molecular prognostic factors in glioblastoma: state of the art and future challenges

Overexpression of circulating MiR-30b-5p identifies advanced breast cancer

Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma

Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.

Serum lactate levels are associated with glioma malignancy grade

Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion

The cell secretome in personalized and regenerative medicine

The impact of Mesenchymal Stem Cells and their secretome as a treatment for gliomas

The long non-coding RNA HOTAIR is transcriptionally activated by HOXA9 and is an independent prognostic marker in patients with malignant glioma.

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival

Transcriptional profiling of HOXA9-regulated genes in human glioblastoma cell models

Understanding TERT Promoter Mutations: A Common Path to Immortality.

Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene

is a novel oncogenic prognostic biomarker in human glioblastoma